PDF(Pubmed)
Abstract：
The prevalence of depression is high worldwide, and somatic symptoms are known to be one of the most debilitating aspects of depression. However, clinicians often face challenges in accurately assessing this comorbidity. To address this issue, the Depression and Somatic Symptoms Scale (DSSS) was developed as a self-administered scale that can diagnose both depression and somatic symptoms. The objective of this study is to evaluate the validity and reliability of the Arabic-translated version of the DSSS (A-DSSS) in a sample of Lebanese adults, as well as to explore its associated factors. A cross-sectional study was conducted over a period of one month, from February to March 2023, and involved a sample of 422 participants who were aged 18 years or older. Participants completed a questionnaire that included various measures, including demographic characteristics, alcohol and smoking habits, physical activity history, as well as two scales: the Patient Health Questionnaire-9 (PHQ9) scale and the A-DSSS scale. The A-DSSS showed high internal consistency (Cronbach\'s alpha = 0.936), strong test-retest reliability (ICC of 0.988 with CI 0.976-0.994; p < 0.001), and a three-factor structure consistent with previous research. Convergent validity was supported by a significant correlation with the PHQ-9. Stepwise linear regression revealed that engaging in physical activity and increasing calorie consumption (as measured by MET-min/week score) were associated with a significant decrease in the A-DSSS total score and subscales. However, a significant increase in the A-DSSS total score was seen in the female gender in comparison for male gender. The A-DSSS revealed good psychometric properties and may be a useful tool for assessing depression and somatic symptoms in this population. The study also identified potential factors associated with depression and somatic symptoms, such as physical activity, calorie consumption, and gender, which may have implications in addressing depression and somatic symptoms for future interventions and clinical practice.
摘要：
抑郁症的患病率在世界范围内很高，和躯体症状被认为是抑郁症最令人衰弱的方面之一。然而,临床医生在准确评估这种共病方面经常面临挑战.为了解决这个问题，抑郁症和躯体症状量表（DSSS）是一种自我管理的量表，可以诊断抑郁症和躯体症状。这项研究的目的是评估阿拉伯翻译版本的DSSS（A-DSSS）在黎巴嫩成年人样本中的有效性和可靠性，以及探讨其相关因素。进行了为期一个月的横断面研究，从2023年2月至3月，纳入了422名18岁或以上参与者的样本。参与者填写了一份问卷，其中包括各种措施，包括人口特征，酒精和吸烟习惯，身体活动史,以及两个量表：患者健康问卷-9（PHQ9）量表和A-DSSS量表。A-DSSS显示出较高的内部一致性（Cronbach'sα=0.936），强重测信度(ICC为0.988，CI为0.976-0.994；p<0.001)，和与以往研究一致的三因素结构。与PHQ-9的显著相关性支持收敛效度。逐步线性回归显示，参加体育锻炼和增加卡路里消耗（通过MET-min/周评分衡量）与A-DSSS总分和分量表的显着降低有关。然而,女性与男性相比,A-DSSS总分显著升高.A-DSSS显示出良好的心理测量特性，可能是评估该人群抑郁和躯体症状的有用工具。该研究还确定了与抑郁症和躯体症状相关的潜在因素，比如身体活动，卡路里消耗,和性别,这可能对解决抑郁症和躯体症状对未来的干预和临床实践有影响。
